These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 33639941)

  • 21. Fasting, non-fasting glucose and HDL dysfunction in risk of pre-diabetes, diabetes, and coronary disease in non-diabetic adults.
    Onat A; Can G; Çiçek G; Ayhan E; Doğan Y; Kaya H
    Acta Diabetol; 2013 Aug; 50(4):519-28. PubMed ID: 21769500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population-based incidence of type 2 diabetes in northern Spain: the Asturias Study.
    Valdés S; Botas P; Delgado E; Alvarez F; Cadórniga FD
    Diabetes Care; 2007 Sep; 30(9):2258-63. PubMed ID: 17536076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fasting plasma glucose as initial screening for diabetes and prediabetes in irish adults: The Diabetes Mellitus and Vascular health initiative (DMVhi).
    Sinnott M; Kinsley BT; Jackson AD; Walsh C; O'Grady T; Nolan JJ; Gaffney P; Boran G; Kelleher C; Carr B
    PLoS One; 2015; 10(4):e0122704. PubMed ID: 25874867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Serum PCSK9 Levels in Subjects with Normoglycemia, Impaired Fasting Glucose, and Impaired Glucose Tolerance.
    Han E; Cho NH; Moon SS; Cho H
    Endocrinol Metab (Seoul); 2020 Jun; 35(2):480-483. PubMed ID: 32615732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spousal cardiometabolic risk factors and incidence of type 2 diabetes: a prospective analysis from the English Longitudinal Study of Ageing.
    Nielsen J; Hulman A; Witte DR
    Diabetologia; 2018 Jul; 61(7):1572-1580. PubMed ID: 29520580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determinants of the progression to type 2 diabetes and regression to normoglycemia in people with pre-diabetes: A population-based cohort study over ten years.
    Kohansal K; Ahmadi N; Hadaegh F; Alizadeh Z; Azizi F; Habibi-Moeini AS; Khalili D
    Prim Care Diabetes; 2022 Dec; 16(6):797-803. PubMed ID: 36404444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of change in fasting glucose on the risk of myocardial infarction, stroke, and all-cause mortality: a nationwide cohort study.
    Lee G; Kim SM; Choi S; Kim K; Jeong SM; Son JS; Yun JM; Park SM
    Cardiovasc Diabetol; 2018 Apr; 17(1):51. PubMed ID: 29626936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BMI and All-Cause Mortality in Normoglycemia, Impaired Fasting Glucose, Newly Diagnosed Diabetes, and Prevalent Diabetes: A Cohort Study.
    Lee EY; Lee YH; Yi SW; Shin SA; Yi JJ
    Diabetes Care; 2017 Aug; 40(8):1026-1033. PubMed ID: 28400430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma Metabolomics to Identify and Stratify Patients With Impaired Glucose Tolerance.
    Wildberg C; Masuch A; Budde K; Kastenmüller G; Artati A; Rathmann W; Adamski J; Kocher T; Völzke H; Nauck M; Friedrich N; Pietzner M
    J Clin Endocrinol Metab; 2019 Dec; 104(12):6357-6370. PubMed ID: 31390012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: results of a cohort study.
    Giordanino C; Bugianesi E; Smedile A; Ciancio A; Abate ML; Olivero A; Pellicano R; Cassader M; Gambino R; Bo S; Ciccone G; Rizzetto M; Saracco G
    Am J Gastroenterol; 2008 Oct; 103(10):2481-7. PubMed ID: 18702647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk and population attributable fraction of metabolic syndrome and impaired fasting glucose for the incidence of type 2 diabetes mellitus among middle-aged Japanese individuals: Aichi Worker's Cohort Study.
    Kaneko K; Yatsuya H; Li Y; Uemura M; Chiang C; Hirakawa Y; Ota A; Tamakoshi K; Aoyama A
    J Diabetes Investig; 2020 Sep; 11(5):1163-1169. PubMed ID: 32022993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between estimated glomerular filtration rate and reversion to normoglycemia in people with impaired fasting glucose: a 5-year retrospective cohort study.
    Tu L; Hu H; Zhou X; Zhang H; Liu X; Yang D; He Y
    Eur J Med Res; 2024 Feb; 29(1):140. PubMed ID: 38388456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fasting proinsulin concentrations predict the development of type 2 diabetes.
    Wareham NJ; Byrne CD; Williams R; Day NE; Hales CN
    Diabetes Care; 1999 Feb; 22(2):262-70. PubMed ID: 10333943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations of a metabolic syndrome severity score with coronary heart disease and diabetes in fasting vs. non-fasting individuals.
    DeBoer MD; Filipp SL; Gurka MJ
    Nutr Metab Cardiovasc Dis; 2020 Jan; 30(1):92-98. PubMed ID: 31662283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The characteristics of impaired fasting glucose associated with obesity and dyslipidaemia in a Chinese population.
    Qian Y; Lin Y; Zhang T; Bai J; Chen F; Zhang Y; Luo S; Shen H
    BMC Public Health; 2010 Mar; 10():139. PubMed ID: 20233452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrated biomarker for type 2 diabetes mellitus and impaired fasting glucose based on metabolomics analysis using ultra-high performance liquid chromatography quadrupole-Orbitrap high-resolution accurate mass spectrometry.
    Long J; Liu L; Jia Q; Yang Z; Sun Z; Yan C; Yan D
    Rapid Commun Mass Spectrom; 2020 Jun; 34(12):e8779. PubMed ID: 32159245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. White blood-cell count and the risk of impaired fasting glucose or Type II diabetes in middle-aged Japanese men.
    Nakanishi N; Yoshida H; Matsuo Y; Suzuki K; Tatara K
    Diabetologia; 2002 Jan; 45(1):42-8. PubMed ID: 11845222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Energy drink intake and metabolic syndrome: A prospective investigation in young adults.
    Trapp G; Hurworth M; Jacoby P; Christian H; Ambrosini G; Oddy W; Straker L; Mori T; Beilin L; Allen K
    Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1679-1684. PubMed ID: 32807639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Acarbose on Incident Diabetes and Regression to Normoglycemia in People With Coronary Heart Disease and Impaired Glucose Tolerance: Insights From the ACE Trial.
    Gerstein HC; Coleman RL; Scott CAB; Xu S; Tuomilehto J; Rydén L; Holman RR;
    Diabetes Care; 2020 Sep; 43(9):2242-2247. PubMed ID: 32641379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resting heart rate and the risk of developing impaired fasting glucose and diabetes: the Kailuan prospective study.
    Wang L; Cui L; Wang Y; Vaidya A; Chen S; Zhang C; Zhu Y; Li D; Hu FB; Wu S; Gao X
    Int J Epidemiol; 2015 Apr; 44(2):689-99. PubMed ID: 26002923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.